Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Study Identifier:
CLI-06001AA2-01
ClinicalTrials.gov Identifier:
NCT06029595
EudraCT Identifier:
2022-502208-64-00
Study Contact Information:
N/A
Active, not recruiting

Study Details

Medical Condition
  • Uncontrolled Asthma
Study Drug
  • Drug: Experimental: CHF6001 3200 μg
  • Drug: Placebo Comparator: CHF6001 Placebo
Date
Nov 2023 - Mar 2026
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 75 Years
Requirements Information
Healthy Volunteers
No

Protocol Summary

The purpose of this study is to evaluate the efficacy and safety of CHF6001 (Tanimilast) as add-on to maintenance of inhaled corticosteroids in combination with Long-acting ß2-agonists in the target patient population. (TANGO)

Study Locations

Location
Status
Location
Site 032020 - Instituto Especialidades de la Salud Rosario - Clinica del Torax
Santa Fe, La, Argentina
Status
N/A
Location
Site 032027- Centro de Medicina Respiratoria
Argentina, Argentina
Status
N/A
Location
Site 032025 - Sala Mignaburu
Berazategui, Argentina
Status
N/A
Location
Site 032004 - CARE - Centro de Alergia y Enfermedades Respiratorias
Buenos Aires, Argentina
Status
N/A
Location
Site 032014 - Instituto de Investigaciones en Alergia y Enfermedades Respiratorias (INAER)
Buenos Aires, Argentina
Status
N/A
Location
Site 032021 - Centro De Investigaciones Medicas Mar Del Plata
Buenos Aires, Argentina
Status
N/A